JP5266627B2 - Oral composition - Google Patents
Oral composition Download PDFInfo
- Publication number
- JP5266627B2 JP5266627B2 JP2006197770A JP2006197770A JP5266627B2 JP 5266627 B2 JP5266627 B2 JP 5266627B2 JP 2006197770 A JP2006197770 A JP 2006197770A JP 2006197770 A JP2006197770 A JP 2006197770A JP 5266627 B2 JP5266627 B2 JP 5266627B2
- Authority
- JP
- Japan
- Prior art keywords
- chitosan
- chitin
- taurine
- composition
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000000203 mixture Substances 0.000 title description 33
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 53
- 229920001661 Chitosan Polymers 0.000 claims description 46
- 229920002101 Chitin Polymers 0.000 claims description 35
- 229960003080 taurine Drugs 0.000 claims description 26
- 150000003839 salts Chemical class 0.000 claims description 18
- 235000013361 beverage Nutrition 0.000 claims description 16
- 235000019658 bitter taste Nutrition 0.000 claims description 15
- 235000019645 odor Nutrition 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 7
- 239000000796 flavoring agent Substances 0.000 description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 235000013305 food Nutrition 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 4
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 4
- 235000019606 astringent taste Nutrition 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- -1 polyethylene terephthalate Polymers 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- 229940116269 uric acid Drugs 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 230000002401 inhibitory effect Effects 0.000 description 3
- 230000009965 odorless effect Effects 0.000 description 3
- 239000003002 pH adjusting agent Substances 0.000 description 3
- 235000019640 taste Nutrition 0.000 description 3
- 230000009967 tasteless effect Effects 0.000 description 3
- 229930003231 vitamin Natural products 0.000 description 3
- 239000011782 vitamin Substances 0.000 description 3
- 235000013343 vitamin Nutrition 0.000 description 3
- 229940088594 vitamin Drugs 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 2
- 235000017491 Bambusa tulda Nutrition 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 244000082204 Phyllostachys viridis Species 0.000 description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- 206010039509 Scab Diseases 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 239000011425 bamboo Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 235000013355 food flavoring agent Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000020958 lipid digestion Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000019629 palatability Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 235000011007 phosphoric acid Nutrition 0.000 description 2
- 239000004014 plasticizer Substances 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 229910001414 potassium ion Inorganic materials 0.000 description 2
- 229910001415 sodium ion Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- SPSPIUSUWPLVKD-UHFFFAOYSA-N 2,3-dibutyl-6-methylphenol Chemical compound CCCCC1=CC=C(C)C(O)=C1CCCC SPSPIUSUWPLVKD-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- 241000254032 Acrididae Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- 241000254173 Coleoptera Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000238424 Crustacea Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 241000239366 Euphausiacea Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 235000005135 Micromeria juliana Nutrition 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 240000002114 Satureja hortensis Species 0.000 description 1
- 235000007315 Satureja hortensis Nutrition 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 235000011054 acetic acid Nutrition 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229960001777 castor oil Drugs 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000007405 data analysis Methods 0.000 description 1
- 230000003544 deproteinization Effects 0.000 description 1
- 235000013325 dietary fiber Nutrition 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 229910000397 disodium phosphate Inorganic materials 0.000 description 1
- 235000019800 disodium phosphate Nutrition 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 150000002314 glycerols Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 1
- 235000019796 monopotassium phosphate Nutrition 0.000 description 1
- 235000021096 natural sweeteners Nutrition 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000013588 oral product Substances 0.000 description 1
- 229940023486 oral product Drugs 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 229940068965 polysorbates Drugs 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 239000001587 sorbitan monostearate Substances 0.000 description 1
- 235000011076 sorbitan monostearate Nutrition 0.000 description 1
- 229940035048 sorbitan monostearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000005846 sugar alcohols Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- AOBORMOPSGHCAX-DGHZZKTQSA-N tocofersolan Chemical compound OCCOC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C AOBORMOPSGHCAX-DGHZZKTQSA-N 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
本発明は、キチン、キトサン及び/又はそれらの塩若しくは誘導体が呈する不快臭、渋みやえぐみに代表される苦味が低減された経口用組成物に関する。 The present invention relates to an oral composition in which the unpleasant odor exhibited by chitin, chitosan and / or a salt or derivative thereof, bitterness typified by astringency and sashimi is reduced.
キチンやキトサンは機能性食物繊維の一種であり、脂質の消化吸収を阻害する効果(特許文献1)、血清コレステロール濃度上昇抑制効果(非特許文献1)キトサン の血清尿酸値上昇抑制効果や血清尿酸値改善効果等(特許文献2)を有することが知られている。またこの他にも、キチン、キトサンは抗菌性、創傷治癒作用、凝集性、保湿性等において優れた作用を有する。 Chitin and chitosan are a kind of functional dietary fiber, which inhibits lipid digestion and absorption (Patent Document 1), suppresses serum cholesterol concentration increase (Non-patent Document 1), suppresses serum uric acid level increase effect and serum uric acid It is known to have a value improvement effect or the like (Patent Document 2). In addition to these, chitin and chitosan have excellent actions in antibacterial properties, wound healing action, cohesiveness, moisture retention and the like.
かかる効果を効率的に享受することを目的として、キチンやキトサン、あるいは易溶解性キトサン(特許文献3)を含む食品が開発されている。しかし、この様なキトサンやその誘導体を食品とするに際しての問題は、その不快な味と風味にある。特にキトサンや易溶解性キトサンは、特有の臭い(生臭さ)と渋みやえぐ味等の苦味を有しており、キトサンを継続的にあるいは多量に摂取することの障害となっている。 Foods containing chitin, chitosan, or easily soluble chitosan (Patent Document 3) have been developed for the purpose of efficiently enjoying such effects. However, the problem when using such chitosan or its derivatives as food is its unpleasant taste and flavor. In particular, chitosan and easily soluble chitosan have a peculiar smell (raw odor) and bitterness such as astringency and savory taste, and are an obstacle to taking chitosan continuously or in large quantities.
キチンやキトサンを含む飲食品の風味改善方法としては、無機酸のカルシウム塩及び/又は硫酸塩を添加する方法(特許文献4)、柿の葉の粉末あるいは柿の葉の抽出エキスを添加する方法(特許文献5)、トレハロースなどの糖類やグリシン、キサンタンガム等を加える方法(特許文献6)等が知られている。 As a method for improving the flavor of foods and drinks containing chitin and chitosan, a method of adding calcium salt and / or sulfate of inorganic acid (Patent Document 4), a method of adding bamboo leaf powder or bamboo leaf extract (Patent Document 5), a method of adding sugars such as trehalose, glycine, xanthan gum and the like (Patent Document 6) are known.
しかしながら、これらの方法によってもキチンやキトサンの不快臭や苦味が充分に抑制するまでには至っていない。 However, these methods have not yet sufficiently suppressed the unpleasant odor and bitterness of chitin and chitosan.
本発明は、キトサンの不快臭ならびに苦味を改善し、日常的に無理なくキトサンを多量に摂取することのできるキトサン含有食品を提供することを目的とする。 An object of the present invention is to provide a chitosan-containing food that improves the unpleasant odor and bitterness of chitosan, and allows daily intake of large amounts of chitosan without difficulty.
本発明者らは、それ自体は無味無臭であるタウリンを配合することにより、キトサンの不快臭や苦味が改善され、より服用し易い経口用組成物が得られることを見いだし、下記の各発明を完成した。 The present inventors have found that an unpleasant odor and bitterness of chitosan are improved by blending taurine, which is itself tasteless and odorless, and an oral composition that is easier to take can be obtained. completed.
(1)0.1〜10重量%のタウリンならびにキチン、キトサン及び/又はその塩若しくは誘導体を含有する経口用組成物。 (1) An oral composition containing 0.1 to 10% by weight of taurine and chitin, chitosan and / or a salt or derivative thereof.
(2)キチン、キトサン及び/又はその塩若しくは誘導体1重量部に対してタウリンを2〜100重量部含む、(1)に記載の経口用組成物。 (2) The oral composition according to (1), comprising 2 to 100 parts by weight of taurine with respect to 1 part by weight of chitin, chitosan and / or a salt or derivative thereof.
(3)飲料である、(1)又は(2)に記載の経口用組成物。 (3) The composition for oral administration according to (1) or (2), which is a beverage.
(4)pHが2.5〜7である、(3)に記載の経口用組成物。 (4) The oral composition according to (3), wherein the pH is 2.5-7.
本発明の組成物は、従来問題とされていたキチン、キトサン及び/又はそれらの塩若しくは誘導体の臭いや苦味が改良された、極めて服用しやすい経口用組成物を提供することができる。特に、タウリン自体は無味無臭であるため、別途適当な香料や矯味剤を利用することで、キチン、キトサン及び/又はそれらの塩若しくは誘導体の臭いや苦味をマスキングする一方で様々なフレーバーを持つ経口用組成物を提供することができる。 The composition of the present invention can provide an oral composition that is extremely easy to take and has improved odor and bitterness of chitin, chitosan and / or salts or derivatives thereof, which have been considered as a problem in the past. In particular, since taurine itself is tasteless and odorless, it is possible to mask the odor and bitterness of chitin, chitosan and / or their salts or derivatives by using an appropriate perfume and flavoring agent. A composition can be provided.
また、キチンやキトサンの生理作用、例えば脂質の消化吸収阻害作用、血清コレステロール濃度上昇抑制作用、血清尿酸値上昇抑制作用、血清尿酸値改善作用、その他抗菌性、創傷治癒作用、凝集性、保湿性等を享受するには、キチン、キトサン及び/又はそれらの塩若しくは誘導体の摂取量を増やすことが重要であるが、キチン、キトサン及び/又はそれらの塩若しくは誘導体を多量に摂取することは、同時にその臭いや苦味をより長く又は強く感じることを意味する。本発明は、このキチン、キトサン及び/又はそれらの塩若しくは誘導体の大量服用時に感じやすい臭いや苦味を、タウリンというそれ自体が人の健康に対して種々の利益をもたらす物質によって低減することができるので、キチン、キトサン及び/又はそれらの塩若しくは誘導体の大量摂取による恩恵とタウリンに由来する効果を同時に享受することを可能にするものである。 Physiological effects of chitin and chitosan, such as lipid digestion and absorption inhibitory effect, serum cholesterol level increase inhibitory effect, serum uric acid level increase inhibitory effect, serum uric acid level improvement effect, other antibacterial properties, wound healing effect, cohesiveness, moisture retention It is important to increase the intake of chitin, chitosan and / or their salts or derivatives, but ingesting large amounts of chitin, chitosan and / or their salts or derivatives at the same time It means that the smell or bitterness is felt longer or stronger. The present invention can reduce the odor and bitterness that are easily felt when taking a large amount of chitin, chitosan and / or a salt or derivative thereof by means of taurine, which itself has various benefits for human health. Therefore, it is possible to simultaneously enjoy the benefits derived from large intakes of chitin, chitosan and / or their salts or derivatives and the effects derived from taurine.
キチンは、一般的にカニ、エビ、オキアミ等の甲殻類の甲皮、カブトムシ、バッタ等の昆虫類の甲皮、イカの骨等を脱カルシウム処理し、除タンパク質処理することで製造されている。また、キノコ類、微生物からも得ることができる。このキチンをさらに脱アセチル化処理してキトサンが製造される。 Chitin is generally produced by decalcification and deproteinization of crustacean crusts such as crabs, shrimps and krill, insect crusts such as beetles and grasshoppers, and squid bones. . It can also be obtained from mushrooms and microorganisms. This chitin is further deacetylated to produce chitosan.
本発明は、この様にして得られるキチンやキトサンに対して有効である。また、不快な臭いや苦味を有するキチンやキトサンを含んでいる限り、キチンやキトサンの精製の度合いに制限はなく、未精製品あるいは部分精製品であってもよい。 The present invention is effective for chitin and chitosan thus obtained. In addition, as long as chitin or chitosan having an unpleasant odor or bitter taste is contained, the degree of purification of chitin or chitosan is not limited, and may be an unpurified product or a partially purified product.
さらに、キチンやキトサンの溶解性や風味等を改善する目的で種々の天然型キチンやキトサンあるいはそれらの誘導体も開発され、一部は市販されているが、これら誘導体の中でもキチンやキトサン独特の臭いや苦味を有するものに対しては、本発明を適用することができる。 In addition, various natural chitin and chitosan or their derivatives have been developed for the purpose of improving the solubility and flavor of chitin and chitosan, and some of them are commercially available. Among these derivatives, there are odors unique to chitin and chitosan. The present invention can be applied to those having a bitter taste.
本発明において上記キチン、キトサン及び/又はそれらの塩若しくは誘導体の苦味や風味を改善する作用を示すタウリン(アミノエチルスルホン酸)は、分子量125.15の単純な化学構造をもつ含硫アミノ酸である。タウリンは化学構造的にはアミノ酸に属するが、タンパク質を構成するアミノ酸とは異なり、ビタミン類やホルモンのような作用、さらには脳神経系、循環系、肝胆系をはじめとして様々な薬理作用を示すことが知られている。この様に、タウリンは生理活性物質として注目され、利用されてきたが、その性状は無色または白色の結晶の粉末で臭いも味もないことから、矯味成分として、また特に嗜好性を形成するほどの強い苦味に対してのマスキング成分としては利用されていない。 In the present invention, taurine (aminoethylsulfonic acid), which has an action to improve the bitterness and flavor of the chitin, chitosan and / or salt or derivative thereof, is a sulfur-containing amino acid having a simple chemical structure with a molecular weight of 125.15. . Taurine belongs to amino acids in terms of chemical structure, but unlike amino acids that constitute proteins, taurine has actions like vitamins and hormones, as well as various pharmacological actions including cranial nervous system, circulatory system, and hepatobiliary system. It has been known. Thus, taurine has attracted attention and has been used as a physiologically active substance, but its properties are colorless or white crystalline powder, and it has no odor or taste. It is not used as a masking ingredient for strong bitterness.
一般にキチンやキトサンの有効投与量は、健康成人で一日で1.5g〜3gである。本発明では、キチンやキトサン及び/又はそれらの塩若しくは誘導体1重量部に対してタウリンを2〜100重量部配合して利用することができるが、2〜10重量部とすることが本発明においては好ましい態様である。また組成物全重量当たりで表せば、組成物当たりのタウリンの配合量は0.1〜10重量%、好ましくは0.1〜5重量%、より好ましくは1〜3重量%とすればよい。 In general, the effective dose of chitin and chitosan is 1.5 to 3 g per day for healthy adults. In the present invention, 2 to 100 parts by weight of taurine can be blended and used with respect to 1 part by weight of chitin and chitosan and / or their salts or derivatives. Is a preferred embodiment. In terms of the total weight of the composition, the amount of taurine per composition may be 0.1 to 10% by weight, preferably 0.1 to 5% by weight, more preferably 1 to 3% by weight.
この組み合わせによって、キチンやキトサン及び/又はそれらの塩若しくは誘導体が呈する比較的強い苦味を無味無臭のタウリンによって低減することができる。 By this combination, the relatively strong bitterness exhibited by chitin and chitosan and / or their salts or derivatives can be reduced by tasteless and odorless taurine.
水溶性を向上させたキチン、キトサンならびにタウリンはいずれも水溶液中で比較的安定な化合物であることから、本発明における好適な形態は飲料であり、特にpHが2.5〜7、好ましくは4.5〜6.5に調整されている、容器詰の飲料である。本発明の経口用組成物である飲料においては、かかる範囲のpHに設定することによって、より服用感が向上することが確認された。 Since all of chitin, chitosan and taurine with improved water solubility are relatively stable compounds in an aqueous solution, the preferred form in the present invention is a beverage, and particularly has a pH of 2.5 to 7, preferably 4 It is a packaged beverage that is adjusted to .5 to 6.5. In the drink which is the composition for oral use of this invention, it was confirmed that a feeling of dosing improves more by setting to pH of this range.
pHは適当なpH調節剤を用いて調整すればよい。pH調整剤としては、有機及び無機の食用酸を用いることができる。酸はそれらの非解離形で、あるいはそれらの各塩、例えばリン酸水素カリウム又はナトリウム、リン酸二水素カリウム又はナトリウム塩のような形態で用いてもよい。好ましい酸は、クエン酸、リンゴ酸、フマル酸、アジピン酸、リン酸、グルコン酸、酒石酸、アスコルビン酸、酢酸、リン酸又はそれらの混合物を含めた食用有機酸である。また、重炭酸塩も用いることができる。 The pH may be adjusted using an appropriate pH adjuster. As the pH adjuster, organic and inorganic edible acids can be used. The acids may be used in their undissociated form or in the form of their respective salts, such as potassium or sodium hydrogen phosphate, potassium dihydrogen phosphate or sodium salt. Preferred acids are edible organic acids including citric acid, malic acid, fumaric acid, adipic acid, phosphoric acid, gluconic acid, tartaric acid, ascorbic acid, acetic acid, phosphoric acid or mixtures thereof. Bicarbonate can also be used.
この様にpHが調整された飲料として本発明にかかる経口用組成物を製造するには、同飲料は容器詰の形態で製造されることが好ましい。容器の種類に特に制限はないが、ポリエチレンテレフタレートを主成分とする成形容器(いわゆるPETボトル)、金属缶、金属箔やプラスチックフィルムと複合された紙容器、瓶など、いずれの容器も利用することができる。 In order to produce the oral composition according to the present invention as a beverage whose pH is adjusted in this way, the beverage is preferably produced in a container form. There are no particular restrictions on the type of container, but any container such as a molded container (so-called PET bottle) mainly composed of polyethylene terephthalate, a metal can, a paper container combined with a metal foil or plastic film, or a bottle should be used. Can do.
また、本発明の経口用組成物において、特に生理電解質であるナトリウムイオンやカリウムイオンを配合することによって、いわゆるスポーツ飲料やアイソトニック飲料とすることも有益である。ナトリウムイオンやカリウムイオンの他にも、ミネラル類としてカルシウム、クロム、銅、鉄、マグネシウム、マンガン、リン、セレン、ケイ素、モリブデンまたは亜鉛等を添加することもできる。 In addition, in the oral composition of the present invention, it is also advantageous to make so-called sports drinks and isotonic drinks by blending sodium ions and potassium ions, which are physiological electrolytes. In addition to sodium ions and potassium ions, calcium, chromium, copper, iron, magnesium, manganese, phosphorus, selenium, silicon, molybdenum, zinc, or the like can be added as minerals.
さらに、嗜好性を高めるために、適宜甘味料を選択して配合してもよい。例えば、ステビアなどの天然甘味料、アスパルテーム等の人工甘味料類、蔗糖等の炭水化物類、ソルビトール、エリスリトール、キシリトール等の糖アルコール、グリセリン等のグリセロール類を利用することができる。 Furthermore, in order to improve palatability, you may select and mix | blend a sweetener suitably. For example, natural sweeteners such as stevia, artificial sweeteners such as aspartame, carbohydrates such as sucrose, sugar alcohols such as sorbitol, erythritol, and xylitol, and glycerols such as glycerin can be used.
本発明の経口用組成物の調製に際しては、特別な界面活性剤等の添加物は必須ではないが、必要に応じて他の公知の添加剤、賦形剤その他を加えて適当な剤型へと加工してもよい。例えば液剤であれば、抗酸化剤、着色剤、矯味矯臭剤、界面活性剤、可塑剤、pH調整剤などを混合して常法により、ドライシロップ剤、液剤などの経口物とすることができる。また固形剤であれば、賦形剤、崩壊剤、結合剤、滑沢剤、抗酸化剤、コーティング剤、着色剤、矯味矯臭剤、界面活性剤、可塑剤などを混合して常法により、顆粒剤、散剤、カプセル剤、錠剤などを製造することができる。 In the preparation of the oral composition of the present invention, special additives such as surfactants are not essential, but other known additives, excipients, etc. may be added to an appropriate dosage form as necessary. And may be processed. For example, in the case of a liquid agent, an antioxidant, a colorant, a flavoring agent, a surfactant, a plasticizer, a pH adjuster, etc. can be mixed to obtain an oral product such as a dry syrup agent or a liquid agent. If it is a solid agent, an excipient, a disintegrant, a binder, a lubricant, an antioxidant, a coating agent, a coloring agent, a corrigent, a surfactant, a plasticizer, etc. are mixed in a conventional manner. Granules, powders, capsules, tablets and the like can be produced.
抗酸化剤としては、例えばビタミンC、ジブチルヒドロキシトルエン(BHT)、没食子酸プロピル、ブチルヒドロキシアニソール(BHT)、α−トコフェロール、クエン酸などが挙げられる。 Examples of the antioxidant include vitamin C, dibutylhydroxytoluene (BHT), propyl gallate, butylhydroxyanisole (BHT), α-tocopherol, and citric acid.
着色剤としては、例えばタール色素、酸化チタンなどが挙げられる。 Examples of the colorant include tar dyes and titanium oxide.
界面活性剤としては、例えばポリグリセリン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、モノステアリン酸ソルビタン、モノパルミチン酸ソルビタン、モノラウリン酸ソルビタン、ポリオキシエチレンポリオキシプロピレンブロックコポリマー、ポリソルベート類、ラウリル硫酸ナトリウム、マクロゴール類、ショ糖脂肪酸エステルなどが挙げられる。 Examples of the surfactant include polyglycerin fatty acid ester, polyoxyethylene hydrogenated castor oil, sorbitan monostearate, sorbitan monopalmitate, sorbitan monolaurate, polyoxyethylene polyoxypropylene block copolymer, polysorbates, sodium lauryl sulfate, macro Examples include galls and sucrose fatty acid esters.
また、必要に応じてタウリンあるいはキトサンの他に各種の生理活性成分、例えばビタミン類などを混合することもできる。好ましいビタミン類としては、ビタミンA、ビタミンB、ビタミンC、ビタミンD及びビタミンEもしくはそれらの各種誘導体を挙げることができる。 In addition to taurine or chitosan, various physiologically active ingredients such as vitamins can be mixed as necessary. Preferable vitamins include vitamin A, vitamin B, vitamin C, vitamin D, vitamin E or various derivatives thereof.
また、本発明の組成物に嗜好性を持たせるために、各種の香料等を添加しても良い。 Moreover, in order to give palatability to the composition of this invention, you may add various fragrance | flavors.
以下に実施例を挙げて本発明をさらに詳細に説明するが、本発明はこれらの実施例に限定されるものではない。 EXAMPLES The present invention will be described in more detail with reference to examples below, but the present invention is not limited to these examples.
市販のキチン(焼津水産化学工業(株)、商品名NA−COS−Y)5gとタウリン10gを精製水に溶解して全量を1000mlとし、飲料組成物を得た。この組成物のpHは3.8である。 5 g of commercially available chitin (Yaizu Suisan Kagaku Kogyo Co., Ltd., trade name NA-COS-Y) and 10 g of taurine were dissolved in purified water to make a total volume of 1000 ml to obtain a beverage composition. The pH of this composition is 3.8.
市販のキチン(焼津水産化学工業(株)、商品名NA−COS−Y)5gとタウリン30gを精製水に溶解して全量を1000mlとし、飲料組成物を得た。この組成物のpHは3.8である。 5 g of commercially available chitin (Yaizu Suisan Kagaku Kogyo Co., Ltd., trade name NA-COS-Y) and 30 g of taurine were dissolved in purified water to make a total volume of 1000 ml to obtain a beverage composition. The pH of this composition is 3.8.
市販のキトサン(焼津水産化学工業(株)、商品名COS−YS)5gとタウリン10gを精製水に溶解して全量を1000mlとし、飲料組成物を得た。この組成物のpHは4.4である。 5 g of commercially available chitosan (Yaizu Suisan Kagaku Kogyo Co., Ltd., trade name COS-YS) and 10 g of taurine were dissolved in purified water to a total volume of 1000 ml to obtain a beverage composition. The pH of this composition is 4.4.
市販のキトサン(焼津水産化学工業(株)、商品名COS−YS)5gとタウリン30gを精製水に溶解して全量を1000mlとし、飲料組成物を得た。この組成物のpHは4.4である。 5 g of commercially available chitosan (Yaizu Suisan Kagaku Kogyo Co., Ltd., trade name COS-YS) and 30 g of taurine were dissolved in purified water to make a total amount of 1000 ml to obtain a beverage composition. The pH of this composition is 4.4.
<試験例>
実施例1〜4で調製した飲料組成物、ならびに実施例1、3からそれぞれタウリンを除いた組成からなるコントロ−ル(それぞれコントロール1、3)の風味について、20歳代〜50歳代の健常な成人男性6名からなるパネラーによる調査を行った。
<Test example>
About the beverage composition prepared in Examples 1 to 4 and the flavors of the controls (controls 1 and 3 respectively) composed of compositions obtained by removing taurine from Examples 1 and 3, healthy in the 20s to 50s A panel of 6 adult males was surveyed.
実施例1〜4の飲料組成物ならびにコントロール1、3をそれぞれ前記パネラーに飲用させた後、各飲料の渋みについて、「感じない」:5点、「僅かに感じる」:4点、「少し感じる」:3点、「感じる」:2点、「強く感じる」:1点から選択させ、その合計点で判定した。 After the beverage compositions of Examples 1 to 4 and Controls 1 and 3 were each drunk by the paneler, “no feeling”: 5 points, “slightly feel”: 4 points, “feel a little” about the astringency of each beverage “: 3 points,“ feel ”: 2 points,“ feel strongly ”: 1 point was selected, and the total was determined.
なお、検体の服用はダブルブラインドで行い、パネラーは、中味が解らない状況で検体を服用した。データ解析には、SD法による絶対評価法を用いた。この各飲料についてのスコアを表1に示す。 The sample was taken with double blinds, and the paneler took the sample in a situation where the contents were not understood. For data analysis, an absolute evaluation method by the SD method was used. The score for each beverage is shown in Table 1.
この様に、タウリンを添加することで、コントロール1、3でそれぞれ認められている渋みが改善されることが確認された。 Thus, it was confirmed that the astringency recognized by each of Controls 1 and 3 was improved by adding taurine.
市販のキトサン(焼津水産化学工業(株)、商品名COS−YS)50gとタウリン100gを混合し、粉末組成物を得た 50 g of commercially available chitosan (Yaizu Suisan Chemical Co., Ltd., trade name COS-YS) and 100 g of taurine were mixed to obtain a powder composition.
市販のキトサン(焼津水産化学工業(株)、商品名COS−YS)50gとタウリン300gを混合し、粉末組成物を得た。
50 g of commercially available chitosan (Yaizu Suisan Chemical Co., Ltd., trade name COS-YS) and 300 g of taurine were mixed to obtain a powder composition.
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006197770A JP5266627B2 (en) | 2006-07-20 | 2006-07-20 | Oral composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006197770A JP5266627B2 (en) | 2006-07-20 | 2006-07-20 | Oral composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2008024625A JP2008024625A (en) | 2008-02-07 |
JP5266627B2 true JP5266627B2 (en) | 2013-08-21 |
Family
ID=39115634
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2006197770A Expired - Fee Related JP5266627B2 (en) | 2006-07-20 | 2006-07-20 | Oral composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5266627B2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6946029B2 (en) * | 2016-03-30 | 2021-10-06 | エスエス製薬株式会社 | Oral pharmaceutical composition |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02283261A (en) * | 1989-04-19 | 1990-11-20 | Ichimaru Pharcos Co Ltd | Processed food and beverage containing polysaccharide component |
JPH10158158A (en) * | 1996-11-26 | 1998-06-16 | Lion Corp | Antiendtoxinic agent |
JP2001086954A (en) * | 1999-09-20 | 2001-04-03 | Yakult Honsha Co Ltd | Health drink or food |
JP2001136941A (en) * | 1999-11-10 | 2001-05-22 | Toshiko Yamamoto | Drink preparation suppressing body smell |
JP2002154977A (en) * | 2000-09-05 | 2002-05-28 | Kao Corp | Composition for drinking and eating |
JP2003079352A (en) * | 2001-09-10 | 2003-03-18 | Mitsumine Matsumoto | Beverage |
-
2006
- 2006-07-20 JP JP2006197770A patent/JP5266627B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JP2008024625A (en) | 2008-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP4726269B2 (en) | Oral solution | |
JP5595614B1 (en) | Liver hydrolyzate-containing liquid composition | |
JP4284165B2 (en) | Container drink | |
CN103535721B (en) | Improve composition and method of making the same and the application of glutathione concentration in human body | |
JP5162812B2 (en) | Zinc-containing composition for oral administration | |
JP4559345B2 (en) | Liquid seasoning | |
JP5151083B2 (en) | Oral composition | |
JP2018161149A (en) | Liquid food composition | |
WO2007077656A1 (en) | Liquid medicine for internal use | |
TWI377914B (en) | ||
JP5266627B2 (en) | Oral composition | |
JP2008094743A (en) | Ingesting/swallowing ameliorating food | |
WO2013062015A1 (en) | Sweet composition showing reduced bitterness of sweetener having bitter taste, method for reducing bitterness, and food, drink, drug or quasi drug having reduced bitterness | |
JP7044306B2 (en) | Leucine blood concentration increase promoter and its uses | |
JP5167605B2 (en) | Oral composition | |
JP2004210675A (en) | Bone quantity amelioration composition | |
JP2013010799A (en) | Oral composition | |
JP2005110548A (en) | Food composition containing methylsulfonylmethane | |
JP2665764B2 (en) | Calcium aqueous solution | |
KR20150128157A (en) | Taste-masked granules containing vitamin C | |
JP2019041696A (en) | Oral composition | |
JP2002080376A (en) | Biologically active agent and medicine | |
US20040156924A1 (en) | Vitamin C and calcium ascorbate based dietary supplement products | |
JP5359527B2 (en) | Beverage | |
JP4840003B2 (en) | Oral composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20090609 |
|
RD07 | Notification of extinguishment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7427 Effective date: 20090624 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120221 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120417 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120710 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120905 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20121120 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20130214 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20130225 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20130409 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20130422 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 5266627 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
LAPS | Cancellation because of no payment of annual fees |